Zobrazeno 1 - 10
of 59
pro vyhledávání: '"BO RA YOU"'
Publikováno v:
Oncotarget
// Bo Ra You 1 , Bo Ram Han 1 , Woo Hyun Park 1 1 Department of Physiology, Medical School, Institute for Medical Sciences, Chonbuk National University, Jeonju, 561-180, Republic of Korea Correspondence to: Woo Hyun Park, email: parkwh71@chonbuk.ac.k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede84ab26b3c0f49ba83055ca83438bd
https://doi.org/10.18632/oncotarget.14628
https://doi.org/10.18632/oncotarget.14628
Autor:
Woo Hyun Park, Bo Ra You
Publikováno v:
International Journal of Oncology. 48:2197-2204
Mesothelioma is an aggressive tumor which is mainly derived from the pleura of lung. In the present study, we evaluated the anticancer effect of suberoylanilide hydroxamic acid (SAHA), a histone deacetylase (HDAC) inhibitor on human mesothelioma cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01cbf73219daa4cad9847e1e3963f840
https://doi.org/10.3892/ijo.2016.3402
https://doi.org/10.3892/ijo.2016.3402
Publikováno v:
Molecular Medicine Reports. 2015, Vol. 11 Issue 2, p1428-1434. 7p.
Antimycin A induces death of the human pulmonary fibroblast cells via ROS increase and GSH depletion
Autor:
Woo Hyun Park, Bo Ra You
Publikováno v:
International Journal of Oncology. 48:813-820
Antimycin A (AMA) inhibits the growth of various cells via stimulating oxidative stress-mediated death. However, little is known about the anti-growth effect of AMA on normal primary lung cells. Here, we investigated the effects of AMA on cell growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b830a5fab5c97276629bb09cf76c177
https://doi.org/10.3892/ijo.2015.3276
https://doi.org/10.3892/ijo.2015.3276
Publikováno v:
Biochim Biophys Acta Mol Basis Dis
Activation of costimulatory receptor 4-1BB enhances T helper 1 (Th1) and CD8 T cell responses in protective immunity, and prevents or attenuates several autoimmune diseases by increasing Treg numbers and suppressing Th17 or Th2 effector response. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e4dd2aa18f42aafe58ff3535d41b8a
https://doi.org/10.1016/j.bbadis.2019.165605
https://doi.org/10.1016/j.bbadis.2019.165605
Autor:
Woo Hyun Park, Bo Ra You
Publikováno v:
Journal of Cellular Biochemistry. 117:1250-1261
Suberoyl bishydroxamic acid (SBHA), a histone deacetylase (HDAC) inhibitor, can show an anticancer effect. In this study, we investigated the effects of SBHA on the growth inhibition and death of Calu-6 and NCI-H1299 cells in relation to reactive oxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b498f7a8fe27bb5572a7f233a7cb5b72
https://doi.org/10.1002/jcb.25409
https://doi.org/10.1002/jcb.25409
Autor:
Woo Hyun Park, Bo Ra You
Publikováno v:
Oncology Reports. 35:546-551
Mesothelioma is an aggressive tumor associated with asbestos exposure. Auranofin as an inhibitor of thioredoxin reductase (TrxR) affects many biological processes such as inflammation and proliferation. In the present study, we investigated the cellu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a7fb8c7c8b72683e6765f6f4faf06c
https://doi.org/10.3892/or.2015.4382
https://doi.org/10.3892/or.2015.4382
Publikováno v:
Molecular Medicine Reports. 11:1428-1434
Auranofin (Au), an inhibitor of thioredoxin reductase, is a known anti‑cancer drug. In the present study, the anti‑growth effect of Au on HeLa cervical cancer cells was examined in association with levels of reactive oxygen species (ROS) and glut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab4bf506ab343838fe1044198c573a9
https://doi.org/10.3892/mmr.2014.2830
https://doi.org/10.3892/mmr.2014.2830
Autor:
Peter R. Hoffmann, Stefan Moisyadi, Woo Hyun Park, Aaron H. Rose, FuKun W. Hoffmann, Bo Ra You, Johann Urschitz, Pietro Bertino
Publikováno v:
Vaccine. 32:1670-1677
DNA vaccination with plasmid has conventionally involved vectors designed for transient expression of antigens in injected tissues. Next generation plasmids are being developed for site-directed integration of transgenes into safe sites in host genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c6b3dec4efaf1c82ae65d3b3b598e7b
https://doi.org/10.1016/j.vaccine.2014.01.063
https://doi.org/10.1016/j.vaccine.2014.01.063
Publikováno v:
Oncology Letters. 2013, Vol. 6 Issue 6, p1804-1810. 7p.